Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Canopy Growth

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Tilray Brands

Cannabis stocks are on track to finish the week higher boosted by the news that the U.S. Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a lower-risk drug.

Cannabis stocks set to end week on a high following marijuana rescheduling recommendation

Canopy Growth (CGC), Tilray (TLRY) and Cronos (CRON) shoot up on news that the DEA is considering recommendations for low-risk reclassification of marijuana.

3 Cannabis Stocks Soaring on HHS' Recommendation to DEA

Cannabis stocks are celebrating this morning after the U.S. Department of Health and Human Services recommended in a letter to the Drug Enforcement Administration that Marijuana be reclassified as a Schedule III drug.

Why are cannabis stocks trading significantly up on Thursday?

Aurora Cannabis

AdvisorShares Pure US Cannabis ETF

OrganiGram Holdings Inc.

Shares of marijuana companies climbed as much as 14% in morning trading on Thursday after the Department of Health and Human Services recommended its reclassification as a lower-risk substance following an 11-month review.

Pot firms gain as US move to ease curbs boosts sentiment

Innovative Industrial Properties

SNDL Inc.

The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug, reviving hope among investors and marijuana producers for an industry that took off like a rocket five years ago before sinking like a rock less than two years later.

Will a Change to US Marijuana Policy Save Any of the Weed Companies?

The continued lack of legalization of marijuana at the federal level is preventing greater growth across the industry. That could change by the end of this year.

3 Cannabis Stocks Poised for Blazing-Hot Growth in 2024

Assistant Secretary for Health Rachel Levine reportedly requested in a letter to DEA Administrator Anne Milgram that marijuana be downgraded to a schedule III substance.

Pot stocks rally after health officials ask DEA to reclassify marijuana as lower-risk drug

Roundhill Cannabis ETF

The Drug Enforcement Agency received an official recommendation to downgrade marijuana.  Currently, pot is classified as a Schedule I drug, on par with heroin.

Pot stocks jump as federal agency reportedly seeks to downgrade cannabis from the hard-drug category

That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.

HHS calls for easing restrictions on marijuana, sending cannabis stocks higher

AdvisorShares, the company managing the world's largest hemp exchange-traded fund Poseidon Dynamic Cannabis ETF (NYSEARCA:PSDN), has reported a waning interest in cannabis stocks. The cannabis industry in the U.S. faces harsh realities of supply surplus, declining wholesale prices, stricter regulations, and distribution challenges.

3 Undervalued Cannabis Stocks With Sky-High Return Potential

Village Farms International

Marijuana stock investors are looking to see better trading this week. Over the last few months, there has been an ongoing decline for most of the sector. Now over the last 4 to 6 weeks, there has been some volatile pops for cannabis stocks. Back at the start of August news on a new federal reform bill led to seeing a slight recovery. Also, this month cannabis companies released their Q2 2023 financial results.

3 Canadian Marijuana Stocks To Buy This Week 2023

Cannabis stocks are far from creating sustainable values. There have been two instances when cannabis stocks have skyrocketed on hopes of robust growth and legalization in the last five years.

3 Millionaire-Maker Cannabis Stocks to Hold Through Thick and Thin

High Tide

As Canada's cannabis sector grows, knowledgeable investors look for chances in marijuana penny stocks in 2023. These lower-priced stocks have the potential for quick gains, making them tempting to day traders and swing traders looking for quick profits. However, approaching this market with prudence and a strong plan that includes good risk management and technical analysis to understand the peculiar characteristics of penny stocks is critical.

Mid-August 2023 Watchlist: Promising Canadian Cannabis Penny Stocks for Traders

It's safe to say that a lot of the shine has worn off the top cannabis stocks in the past few years. The optimism that preceded legalization hasn't translated to strong businesses generally speaking.

Which Cannabis Stocks Are Best in 2023? We Name the Top 3

For an extended period, cannabis stocks have remained sideways to lower. Obviously, there were fundamental reasons for this price action.

3 Cannabis Stocks That Will Explode in 2024

Bitfarms Ltd

Solid Power

Irrespective of market conditions, investors are attracted towards penny stocks in the quest for multibagger returns. However, just because the stocks are cheap doesn't you you shouldn't be wary of bad investments.

Could These 3 Undervalued Penny Stocks Make You a Millionaire?

Albemarle

Kinross Gold

All investors desire to have several multibagger stocks in their portfolios. One secret to churning out regular investments that fit this category is to buy when the company does not get the attention it deserves.

3 Massively Undervalued Growth Stocks for Multibagger Returns

The cannabis industry has captivated both investors and consumers in recent years. Amidst its diversity, certain standout companies have made their mark by prioritizing people's well-being and striving for sustainable growth.

3 Reasons Why Investors Are Lighting Up Cannabis Stocks Again

Industry-leading balance sheet with $841 million in cash and short-term investments Increased 2023 operating expense savings target to $20 to $25 million Announces additional initiatives to streamline supply chain and improve cash flow Spinach ® was top-10 in retail sales in every category it participates in - flower, edible, vape and pre-roll, in Q2 2023 TORONTO, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announces its 2023 second quarter business results. “I am proud of our team's execution in the second quarter despite facing dynamic market conditions across the countries we operate in,” said Mike Gorenstein, Chairman, President and CEO, Cronos.

Cronos Group Reports 2023 Second Quarter Results

With a rally of almost 20% in the S&P 500 index, investors need to be cautious. It makes sense to wait for a correction in blue-chip or growth stocks that have skyrocketed.

3 Massively Undervalued Penny Stocks for Multibagger Potential

For long, investors in the cannabis industry have pinned hopes on federal-level legalization. Without a doubt, that's a big catalyst for growth for the cannabis industry.

3 Cannabis Stocks That Have 10-Bagger Potential

Amplify Alternative Harvest ETF

Cannabis stocks are down in 2023 due to plateauing demand, rising production costs, fierce competition and stalled legalization efforts at the federal level. Yet, with shares of many top cannabis producers and retailers down by double-digit percentages, it may be time for investors who are bullish on the sector long term to pounce on some cheap cannabis investments.

Looking for a Bargain? 7 Cannabis Stocks to Buy That Are Down 10% in 2023

How long are marijuana stock investors going to hold on? What this means is much of the cannabis sector has an unpredictable way of performing. For example, there is no way to tell or be truly sure when cannabis stock will rise. At one point in time essentially any positive casualty would help bring trading up. For some time that has not been the case so what keeps investors so interested? Well, not all are as confident as others but with how young the cannabis industry still is there is much to stay optimistic about.

3 Marijuana Stocks To Watch First Week Of August

The fascinating world of cannabis! In recent years, this exciting sector has attracted the interest of investors and consumers alike.

3 Cannabis Stocks to Buy Before the Breakout

Carnival

iShares MSCI Emerging Markets ETF

Edwards Lifesciences

Kopin

Oric Pharmaceuticals

Principal Financial Group

Prudential Financial

SPDR S&P 500 ETF Trust

Viatris

The stock market, as measured by the S&P 500 Index SPX, -0.64% ), has been moving upward. The U.S. benchmark index is essentially crawling up the higher “modified Bollinger Bands” (mBB), which is a bit of an overbought condition, but not a sell signal.

You can still run with the stock market's bulls, but watch the exits

News for Cronos Group Stock (CRON)